Research map: Efficacy, Safety, and Maintenance Use of Topical Bexarotene in Early‐Stage Mycosis Fungoides: A Single‐Center Retrospective Real‐World Study

Back to the article

Papers in this map

  1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies · Erik B von Elm · 2007 · 22379 citations · Cited by this paper
  2. Topical Cycling and Systemic Eligibility in Patients With Psoriasis in Japan · 2026 · Related
  3. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) · Elise A. Olsen · 2007 · 1434 citations · Cited by this paper
  4. HPV29 ‐Associated Periungual Epidermoid/Verrucous Cyst · 2026 · Related
  5. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up · Rein Willemze · 2018 · 282 citations · Cited by this paper
  6. IL ‐17 Signaling Inhibitors in Localized Scleroderma: A Single‐Center Case Series of Nine Patients · 2026 · Related
  7. Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell Lymphoma · Debra Breneman · 2002 · 211 citations · Cited by this paper
  8. Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan · 2026 · Related
  9. Topical Chemotherapy in Cutaneous T-cell Lymphoma · Stuart R. Lessin · 2012 · 190 citations · Cited by this paper
  10. Dipeptidyl Peptidase‐4 Inhibitor Use and Risk of Pemphigus Vulgaris and Foliaceus: A Retrospective Cohort Study Using Databases of the Korea National Health Insurance Claims and the National Health Screening Examination · 2026 · Related
  11. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023 · Johanna Latzka · 2023 · 187 citations · Cited by this paper
  12. Claudin‐3 Deficiency Potentially Permits Epidermal Nerve Infiltration and Contributes to Sensitive Skin Pathophysiology · 2026 · Related
  13. British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018 · Di Gilson · 2018 · 166 citations · Cited by this paper
  14. Wound, Pressure Ulcer, and Burn Guidelines (2023)‐6: Guidelines for the Management of Burns, Third Edition · 2026 · Related
  15. Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial · PETER W. HEALD · 2003 · 163 citations · Cited by this paper
  16. Mosaic RASopathy Caused by a Somatic HRAS p. Gly12Ser Variant in a Patient With Malignant Melanoma · 2026 · Related
  17. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management · Alexandra C. Hristov · 2019 · 141 citations · Cited by this paper
  18. Giant Hypertrichotic Pigmented Neurofibroma Mimicking Giant Congenital Melanocytic Nevus in Neurofibromatosis Type 1: A Rare Case Report · 2026 · Related
  19. Evaluation of Low-Dose, Low-Frequency Oral Psoralen–UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides · Pablo Augusto Vieyra-Garcia · 2019 · 52 citations · Cited by this paper
  20. Preserved Foot Function After Repeated Surgical Intervention in Recessive Dystrophic Epidermolysis Bullosa: A 17‐Year Follow‐Up · 2026 · Related
  21. Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA–IIA Mycosis Fungoides · Christiane Querfeld · 2021 · 20 citations · Cited by this paper
  22. Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study · Emily Correia · 2022 · 15 citations · Cited by this paper
  23. Effectiveness and tolerability of chlormethine gel for the management of mycosis fungoides: a multicenter real-life evaluation · Silvia Alberti Violetti · 2024 · 13 citations · Cited by this paper
  24. Bexarotene as maintenance treatment after therapies other than skin‐directed therapy in advanced‐stage mycosis fungoides: a pilot study · Alessandro Pileri · 2019 · 12 citations · Cited by this paper
  25. Skin-Directed Therapies in Mycosis Fungoides: An Update · Maciej Tota · 2025 · 5 citations · Cited by this paper
  26. Impact of narrow‐band ultraviolet B phototherapy on remission and relapses of mycosis fungoides in patients with Fitzpatrick skin III – IV · Hsin‐Yu Huang · 2020 · 3 citations · Cited by this paper
  27. Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences · Larisa J. Geskin · 2023 · 2 citations · Cited by this paper
  28. Comparison of the efficacy of treatment with clobetasol propionate or bexarotene in early-stage mycosis fungoides · Aslı Aksu Çerman · 2024 · 2 citations · Cited by this paper
  29. Untitled · Cited by this paper

Source: OpenAlex (CC0)